Iridaceae extract and compositions containing it
AssigneeSociete L'Oreal S.A.
InventorsLionel Breton, Richard Martin, Olivier De Lacharriere
Life of this patent
Estimating the term…
Abstract
The subject of the present invention, in its most general aspect, is an extract of cells of at least one plant of the Iridaceae family, the said plant being obtained by in vitro culture. The subject of the invention is also compositions containing an extract of cells of at least one plant of the Iridaceae family, the use of the said extracts as antagonist of CGRP and/or of substance P and a process of cosmetic treatment involving one of the said compositions.
Claims55
Extract of root, stem, or leaf cells of at least one plant of the Iridaceae family, said plant being obtained by in vitro culture, which extract of cells upon topical application antagonizes at least one biological effect of substance P or calcitonin gene related peptide (CGRP).
Cosmetic orpharmaceutical composition, which comprises, in a cosmetically or pharmaceutically acceptable medium, an extract of cells of at least one plant of the Iridaceae family and at least one irritant.
Cosmetic orpharmaceutical composition, which comprises, in a cosmetically or pharmaceutically acceptable medium, an extract of cells of at least one plant of the Iridaceae family and a compound that reduces the synthesis, release and/or activity of at least one inflammation mediator.
An improved method of therapy comprising the administration of CGRP antagonist or substance P antagonist, wherein the improvement comprises using as said antagonist at least one extract of cells of at least one plant of the Iridaceae family as antagonist of CGRP and/or substance P.
Extract of undifferentiated cells of at least one plant of the Iridaceae family, said plant being obtained by in vitro culture, which extract of cells upon topical application antagonizes at least one biological effect of substance P or calcitonin gene related peptide (CGRP).
Dependencies are inferred from the claim text.